DLA Piper responds to the CVI2-Thelander 2013 CVC Compensation Report
DLA Piper has commented on the release by the Corporate Venture & Innovation Initiative (CVI2) of the CVI2-Thelander 2013 CVC Compensation Report, which is said to be the first comprehensive examination of the compensation structures for corporate venture capital (CVC) programmes at Global 2009 companies.
Mark Radcliffe, partner at DLA Piper, a founding member or the CVP alliance, said that, given intense global competition, innovation is more critical than ever to the success of companies across a broad spectrum of industries.
He added: ‘CVC programmes have become an important element in the innovation strategies of Global 2009 companies, providing access to new and disruptive technologies.
‘However, many CVC programmes are relatively young and critical issues such as CVC compensation practices are rapidly evolving that require the attention of corporate parents.’
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
Health Alert — Lane v Northern NSW Local Health District (No 3); Psychology Board of Australia v Tubara; and more
DLA Piper has released the 28 July 2014 issue of its Health Alert, which focuses on judgments, legislation and reports in the health sector.
In the midst of the gale-force winds of commentary whipped up by the Google case, we should pause and ask ourselves: just how ground-breaking is this decision?
Analysis from The Lawyer
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.
A new breed of lawyer is smoothing the path for companies entering emerging or unstable jurisdictions